Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F.
Respiratory syncytial virus (RSV) is a global public health burden for which no licensed vaccine exists. To aid vaccine development via increased understanding of the protective antibody response to RSV prefusion glycoprotein F (PreF), we performed structural and functional studies using the human n...
Main Authors: | Wayne Harshbarger, Sai Tian, Newton Wahome, Ankita Balsaraf, Deep Bhattacharya, Desheng Jiang, Ratnesh Pandey, Kunal Tungare, Kristian Friedrich, Nurjahan Mehzabeen, Marco Biancucci, Diana Chinchilla-Olszar, Corey P Mallett, Ying Huang, Zihao Wang, Matthew James Bottomley, Enrico Malito, Sumana Chandramouli |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-11-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1008943 |
Similar Items
-
The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
by: Emanuele Andreano, et al.
Published: (2021-06-01) -
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
by: Iebe Rossey, et al.
Published: (2017-02-01) -
Correction: Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
by: Iebe Rossey, et al.
Published: (2017-11-01) -
Transient opening of trimeric prefusion RSV F proteins
by: Morgan S. A. Gilman, et al.
Published: (2019-05-01) -
Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
by: Ariel Isaacs, et al.
Published: (2021-01-01)